New Age Alpha Advisors LLC Takes Position in Cognex Corporation $CGNX

Key Points

• New Age Alpha Advisors LLC opened a new position in Cognex, buying 20,658 shares worth about $743,000 in the fourth quarter.
• Cognex reported strong quarterly results, with EPS of $0.34 beating estimates and revenue of $268.44 million rising 24.3% year over year.
• Despite recent stock gains, insider selling has been notable: over the past 90 days, insiders sold 224,847 shares worth nearly $15 million, even as analysts maintain a Moderate Buy consensus with a $70.43 price target.

New Age Alpha Advisors LLC purchased a new stake in shares of Cognex Corporation (NASDAQ:CGNX - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 20,658 shares of the scientific and technical instruments company's stock, valued at approximately $743,000.

Other institutional investors have also recently made changes to their positions in the company. REAP Financial Group LLC purchased a new stake in shares of Cognex during the 3rd quarter valued at approximately $27,000. Geneos Wealth Management Inc. raised its position in shares of Cognex by 402.2% during the 1st quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company's stock valued at $27,000 after buying an additional 736 shares during the period. CIBC Private Wealth Group LLC raised its position in shares of Cognex by 74.8% during the 3rd quarter. CIBC Private Wealth Group LLC now owns 764 shares of the scientific and technical instruments company's stock valued at $35,000 after buying an additional 327 shares during the period. Miller Global Investments LLC purchased a new stake in shares of Cognex during the 4th quarter valued at approximately $39,000. Finally, Larson Financial Group LLC raised its position in shares of Cognex by 202.7% during the 4th quarter. Larson Financial Group LLC now owns 1,105 shares of the scientific and technical instruments company's stock valued at $40,000 after buying an additional 740 shares during the period. Hedge funds and other institutional investors own 88.12% of the company's stock.

Insider Transactions at Cognex

In other news, insider Mark Fennell sold 64,873 shares of the company's stock in a transaction on Monday, May 11th. The stock was sold at an average price of $67.05, for a total transaction of $4,349,734.65. Following the sale, the insider owned 11,263 shares of the company's stock, valued at approximately $755,184.15. This represents a 85.21% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Darren Marc Long sold 20,252 shares of the company's stock in a transaction on Wednesday, May 27th. The stock was sold at an average price of $66.34, for a total value of $1,343,517.68. Following the sale, the vice president directly owned 3,990 shares in the company, valued at $264,696.60. This represents a 83.54% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 224,847 shares of company stock valued at $14,975,098. 1.70% of the stock is currently owned by company insiders.

Cognex Stock Down 1.0%

Shares of NASDAQ CGNX opened at $66.01 on Friday. The firm has a market cap of $10.99 billion, a price-to-earnings ratio of 78.58 and a beta of 1.48. Cognex Corporation has a 52-week low of $29.22 and a 52-week high of $71.90. The business's 50 day moving average is $56.65 and its two-hundred day moving average is $47.39.

Cognex (NASDAQ:CGNX - Get Free Report) last posted its quarterly earnings data on Wednesday, May 6th. The scientific and technical instruments company reported $0.34 earnings per share for the quarter, topping analysts' consensus estimates of $0.25 by $0.09. Cognex had a return on equity of 10.89% and a net margin of 13.62%.The business had revenue of $268.44 million for the quarter, compared to analyst estimates of $245.98 million. During the same quarter in the prior year, the company earned $0.14 earnings per share. The company's revenue was up 24.3% on a year-over-year basis. Cognex has set its Q2 2026 guidance at 0.400-0.440 EPS. Analysts anticipate that Cognex Corporation will post 1.41 EPS for the current fiscal year.

Cognex Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 4th. Stockholders of record on Thursday, May 21st will be given a dividend of $0.085 per share. The ex-dividend date of this dividend is Thursday, May 21st. This represents a $0.34 dividend on an annualized basis and a dividend yield of 0.5%. Cognex's dividend payout ratio is currently 40.48%.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the stock. DA Davidson set a $62.00 price target on shares of Cognex and gave the company a "neutral" rating in a research report on Thursday, May 14th. Sanford C. Bernstein reissued an "outperform" rating and issued a $75.00 target price on shares of Cognex in a research report on Thursday, May 7th. TD Cowen reissued a "buy" rating on shares of Cognex in a research report on Tuesday, February 17th. Zacks Research lowered Cognex from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 14th. Finally, Robert W. Baird set a $72.00 target price on Cognex in a research report on Friday, May 8th. One analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat, Cognex currently has a consensus rating of "Moderate Buy" and a consensus price target of $70.43.

About Cognex

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company's product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.

Want to see what other hedge funds are holding CGNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognex Corporation (NASDAQ:CGNX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.